Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent

Sashidhara, K V; Avula, S R; Sharma, Komal; Palnati, G R; Bathula, S R

dc.contributor.author	Sashidhara, K V
dc.contributor.author	Avula, S R
dc.contributor.author	Sharma, Komal
dc.contributor.author	Palnati, G R
dc.contributor.author	Bathula, S R
dc.date.accessioned	2013-03-07T11:02:27Z
dc.date.available	2013-03-07T11:02:27Z
dc.date.issued	2013
dc.identifier.citation	Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent	en
dc.identifier.uri	http://hdl.handle.net/123456789/1025
dc.description.abstract	Development of new, targeted antibreast cancer drug which can treat both the hormone receptor (positive and negative) breast cancers is a very challenging task. The concept of molecular hybridization led us to discover a novel class of coumarin-monastrol hybrid, as a novel breast cancer agent which selectively induce apoptosis in both primary and metastatic breast cancer cell lines.	en
dc.format.extent	367910 bytes
dc.format.mimetype	application/pdf
dc.language.iso	en	en
dc.relation.ispartofseries	C.D.R.I. Communication No. 8364	en
dc.subject	Coumarin	en
dc.subject	Monastrol	en
dc.subject	Hybrids	en
dc.subject	Antibreast tumor	en
dc.title	Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent	en
dc.type	Article	en